Watermark a first-mover with customised website live chat platform
Being on the leading edge of innovation and intellectual property, Watermark is paving the digital path for IP attorney and legal services firms with the unveiling of a website chat bot. Executive General Manager Mark Bisset says the…
Immutep enters into clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, and Pfizer
Immutep Limited is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination of Immutep’s lead immunotherapy product candidate eftilagimod alpha…
Burnet’s qDOS Lab a new approach to bringing innovative technologies to market
Fast-tracking innovative technologies through early proof-of-concept and feasibility stages is a key aim of Burnet Institute’s new initiative, the Quick Development of Solutions Lab (qDOS Lab). Nurturing technologies through key early-stage development phases by adopting a market led approach is a primary focus…
What to do when an R&D tax incentive claim goes bad
The R&D tax incentive program is the Government’s largest program designed to support business innovation. It has been reviewed multiple times, with each review concluding it provides significant benefits to the Australian economy, far beyond the cost. AusIndustry…
Sienna appoints exclusive distribution partner for mainland China
Sienna Cancer Diagnostics Ltd has appointed Shaanxi GaoYuan In Vitro Diagnostic Reagents Co. (“GaoYuan”) as the Company’s exclusive distribution partner for mainland China. The distribution agreement for mainland China is a milestone in Sienna’s geographical expansion strategy. The agreement…
Immutep TACTI-mel patient recruitment completed, operational update & Canadian IMP731 patent
Immutep today reports in its operational update that the final patient in Part B of the ongoing TACTI-mel Phase I clinical trial in Australia has now been recruited and is receiving treatment. Patients will be treated for up…
BioCurate launches first round of project investments
BioCurate Pty Ltd has achieved an important milestone announcing investments in six early drug discovery projects from research groups at The University of Melbourne and Monash University. These projects represent the first tranche of investments for BioCurate: Dr…
Victorian Cancer Agency Cancer Health Services Research grants awarded
As part of the Victorian Government’s Victoria Cancer Action Plan 2016-2020, five of the state’s most brilliant scientific minds will receive $1.5 million in grants to support their ground-breaking discoveries and medical breakthroughs in cancer research. The grants,…
Expressions of interest for membership to TGA’s statutory advisory committees
The Therapeutic Goods Administration (TGA) is seeking expressions of interest (EOI) from professionals with expertise in relevant scientific and medical fields or appropriate consumer health issues to support our functions as a best practice regulator. As a committee…
Kesem Health selected for ANDHealth+ 2018
Kesem Health announced today it succeeded in securing a place in Australian’s only mid-stage digital health program, ANDHealth+. Kesem Health will receive up to $60,000 worth of specialist third-party services and up to $150,000 of in-kind support to…
Davies Collison Cave announces 20 promotions and expands it service offering with lateral hire of a new team.
New team and service offering Davies Collison Cave Law is pleased to announce that it has expanded its service offering into the corporate and private client advisory, mergers and acquisitions, tax and property areas with the appointment of…
2018 ATSE Clunies Ross Award Recepients
2018 ATSE Clunies Ross Entrepreneur of the Year: Dr Erol Harvey FTSE TRANSLATING MICRO AND NANO TECHNOLOGY Scientist, educator and entrepreneur Dr Erol Harvey has made outstanding contributions to Australia through the world-leading microfluidic engineering company MiniFAB, his…
